PURPOSE OF REVIEW: To summarize ongoing and recently completed trials on geographic atrophy associated with age-related macular degeneration. RECENT FINDINGS: A large number of investigational agents are under development for treatment of geographic atrophy in both pre and early-phase clinical testing. SUMMARY: Therapies targeting all putative phases of pathogenesis in geographic atrophy are under development. Thus far, no therapies have been demonstrated to be effective.
No takes yet. Share an insight, caveat, or question.
Meleth et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: